In this article by Applied Clinical Trials, Martin Wing-King, the VP and General Manager at Quotient Sciences discusses Optimizing Clinical Trial Efficiency.
Martin talks about the complexity of bringing new treatments to a market and how demand for accelerated pathways to first-in-human (FiH) trials is growing across the pharmaceutical industry.
In addition, Martin discusses streamlined formulation strategy, benefits of simplified formulation, and why working together with experts is key a to accelerating FiH trials.
Continue reading the full article on Applied Clinical Trials